Incyte Corporation is a biopharmaceutical firm engaged in the research, development, and global marketing of its own innovative therapies. Its current product offerings include JAKAFI, prescribed for myelofibrosis and polycythemia vera; PEMAZYRE, a…
Sector
Healthcare
Exchange
NASDAQ
Country
US
Incyte (INCY) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Incyte (INCY) Analysis Tools & Insights
Income Statement